Amedisys, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net income was USD 25.96 million compared to USD 25.64 million a year ago. Basic earnings per share from continuing operations was USD 0.8 compared to USD 0.79 a year ago. Diluted earnings per share from continuing operations was USD 0.79 compared to USD 0.79 a year ago.
For the nine months, net loss was USD 29.07 million compared to net income of USD 86.89 million a year ago. Basic loss per share from continuing operations was USD 0.89 compared to basic earnings per share from continuing operations of USD 2.67 a year ago. Diluted loss per share from continuing operations was USD 0.89 compared to diluted earnings per share from continuing operations of USD 2.66 a year ago.